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Abstract  A  double  blind  randomized  clinical  trial  of  sufentanil  as  an  adjunct  in  spinal  anes-
thesia for  cesarean  section  and,  thereby,  be  able  to  reduce  the  dose  of  bupivacaine,  a  local
anesthetic,  with  the  same  result  of  an  anesthetic  block  with  higher  doses  but  with  fewer
perioperative  side  effects,  such  as  hypotension.
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Introduction
Compared  to  general  anesthesia,  neuraxial  anesthesia  for
cesarean  section  (C-section)  presents  advantages,  such  as
reduced  risk  of  intubation  failure  and  aspiration  of  gas-
tric  contents,  reduced  use  of  depressants  (hypnotics  and
opioids),  and  the  mother’s  consciousness  that  allows  moth-
ers  undergo  the  birth  experience.1,2 Spinal  anesthesia  is
currently  the  most  widely  used  technique  for  C-section,
as  it  provides  intense  sensory  block  and  rapid  installation.
However,  this  technique  can  be  accompanied  by  signiﬁcant
hypotension,  its  most  important  side  effect,  with  reported
incidence  of  20--100%.3--5
Several  strategies  have  been  described  to  prevent  the
occurrence  of  hypotension  in  C-section,  such  as  left  uterine
displacement,  crystalloid  or  colloid  administration,  lower
limb  wrapping,  prophylactic  use  of  ephedrine  or  phenyle-
phrine,  but  none  of  them  eliminated  hypotension.6,7
The  relationship  between  the  local  anesthetic  (LA)  dose
used  and  the  occurrence  of  maternal  hypotension  is  well
established,  with  higher  doses  related  to  a  higher  incidence
of  hypotension.8 However,  the  reduction  of  LA  dose  leads  to
increased  incidence  of  intraoperative  pain.3,9
It  has  been  shown  that  the  combination  of  lipophilic  opi-
oids  with  local  anesthetics  in  spinal  anesthesia  allows  LA
dose  reduction  and  promotes  effective  anesthesia  with  less
side  effects  on  maternal  hemodynamics.10--14
Sufentanil,  highly  soluble,  enhances  analgesia  and  com-
fort  during  surgery,  with  a  short  latency  period  (5--10  min)
and  duration  of  action  of  up  to  7  h.10,15--17 The  use  of  mor-
phine,  soluble  opioid,  is  recommended  to  ensure  longer
postoperative  analgesia.10,18
The  aim  of  this  study  was  to  compare  the  efﬁcacy  of
anesthesia  and  the  incidence  of  side  effects  between  two
hyperbaric  bupivacaine  doses  in  spinal  anesthesia  for  C-
section  with  combined  sufentanil  at  the  lowest  dose.
Material and methods
After  approval  by  the  Ethics  Committee,  the  random-
ized  double-blind  trial  was  started  with  94  women,
aged  18--45  years,  undergoing  C-section  under  spinal
anesthesia.  After  obtaining  written  informed  consent
and  consulting  the  randomization  table,  patients  were
allocated  to  one  of  two  study  groups:  Group  A  (bupiva-
caine  12.5  mg  +  morphine  80  g)  and  Group  S  (bupivacaine
10  mg  +  morphine  80  g  +  sufentanil  5  g).  Syringes  prepara-
tion  and  spinal  anesthesia  administration  were  performed  by
an  anesthesiologist  blinded  to  data  collection.  All  the  inves-
tigators  involved  in  the  study  were  blinded  to  the  assignment
of  each  group.  Pregnant  women  unable  to  decide  on  their
participation  in  the  study  or  unable  to  provide  the  neces-
sary  information,  ASA  IV  or  V,  requiring  emergency  obstetric
care,  with  a  history  of  hypersensitivity  or  allergy  to  any  of
the  study  drugs,  and  those  with  any  contraindication  to  the
technique  proposed  were  excluded.
With  the  patient  in  a  sitting  position,  subarachnoid  punc-
ture  was  performed  in  the  L2--L3,  L3--L4  or  L4--L5  interspace,
with  25G  or  27G  Quincke  needles,  and  the  drugs  were  admin-
istered  according  to  the  group  for  which  it  was  randomized.
Local  anesthetics  and  opioids  were  delivered  in  separate
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yringes  for  a  total  time  of  15  s.  The  patients  were  imme-
iately  placed  in  the  supine  position,  manually  shifting  the
terus  to  the  left  at  an  angle  of  15◦.
Blood  pressure  and  heart  rate  measurements  were
ecorded  before  spinal  anesthesia  and  at  every  3  min  in
he  ﬁrst  15  min,  and  at  30  and  45  min  after  the  blockade.
ypotension  was  deﬁned  as  a  decrease  in  systolic  blood
ressure  (SBP)  up  to  20%  from  baseline  and  controlled  with
ntravenous  ephedrine  (5  mg).  Bradycardia,  deﬁned  as  a
eart  rate  below  80%  of  baseline  or  below  50  bpm  of  base-
ine  value,  was  treated  with  intravenous  atropine  (0.5  mg).
he  level  of  sensory  block  at  T6  dermatome  was  tested  at
,  10,  and  15  min  after  the  blockade  by  pinprick  with  a  22G
eedle.
Symptoms  or  adverse  events,  such  as  nausea,  vomiting,
rowsiness,  pain  above  three  on  the  Visual  Analog  Scale
VAS  >  3)  or  abdominal  discomfort,  in  addition  to  the  neonate
pgar  score  in  the  ﬁrst  and  ﬁfth  minute,  need  to  use  vaso-
ressor  for  hypotension  treatment,  fetal  extraction  time,
nd  duration  of  surgery  were  recorded.  Abdominal  pain  or
iscomfort  during  surgery  was  treated  with  fentanyl  bolus
oses  of  50  g,  repeated  at  the  assistant  physician  discre-
ion.
Postoperative  nausea,  vomiting,  itching,  and  pain  at
est  (VAS  >  3)  at  two,  six,  and  12  h  after  anesthesia  were
ecorded.
Statistical  analysis  was  performed  using  the  Epi  Info®
.1.3.0  software.  Quantitative  variables  were  analyzed
sing  mean  and  standard  deviation  (SD)  and  submitted  to
he  Student  t-test  and  the  frequency  of  qualitative  variables
ere  submitted  to  the  chi-square  and  Fisher  exact  tests  (the
atter  when  the  occurrence  of  variables  was  less  than  ﬁve
nd  this  test  could  be  performed).
esults
n  total,  94  patients  were  selected  and  submitted  to  ran-
omization,  46  patients  in  Group  A  and  48  in  Group  S.  There
ere  two  losses  in  Group  A  due  to  inadequate  completion
f  the  questionnaire  and  one  loss  in  Group  S  due  to  spinal
nesthesia  total  failure  and  need  for  a  second  puncture.
There  was  no  statistically  signiﬁcant  difference  between
he  two  groups  regarding  age  and  body  mass  index  (BMI)  of
atients  and  gestational  age  (Table  1).  The  most  commonly
sed  puncture  site  was  L3--L4,  and  27G  needle  was  the  most
sed  in  both  groups  (Table  2).
The  mean  time  for  fetal  extraction  was  14.16  ±  4.8  min
or  Group  A  and  14.51  ±  4.7  min  for  Group  S,  and  the  mean
uration  of  surgery  was  56.06  ±  11.75  min  for  Group  A  and
7.21  ±  10.88  min  for  Group  S  (Table  3).
The  use  of  ephedrine  to  treat  hypotension  was  similar  in
oth  groups  (30  patients  in  Group  A  and  36  patients  in  Group
,  68.18%  and  76.6%,  respectively)  (Table  4).
The  latency  to  reach  T6  dermatome  was  similar  in  both
roups,  although  the  number  of  patients  who  reached  this
evel  in  5  min  was  higher  in  Group  S  than  in  Group  A (85.11%
s.  70.45%),  but  not  statistically  signiﬁcant.  Over  90%  of
atients  achieved  this  level  up  to  10  min  in  both  groups
Table  5).
624  A.D.  Dourado  et  al.
Table  1  Characteristics  of  patients.
Group  A  (n  =  44)  Group  S  (n  =  47)
Mean  SD  Mean  SD  pa
Age  (years)  26.0227  6.36  27.34  5.99  0.3114
BMI (kg  m−2)  30.64  6.36  32.13  5.43  0.2322
Gestational age  (weeks)  37.9373  2.32  38.31  1.95  0.3976
SD, standard deviation.
a Student’s t-test.
Table  2  Spinal  puncture  data.
Group  A  Group  S
n  =  44  %  n  =  47  %  pa
Puncture  level 0.5436
L2--L3 4  9.09% 2  4.26%
L3--L4 37 84.09% 43  91.49%
L4--L5 3 6.82% 2  4.26%
Needle 0.6615
25G 14  31.82%  17  36.17%
27G 30  68.18%  30  63.83%
a Chi-square test.
Table  3  Surgical  times.
Group  A  (n  =  44)  Group  S  (n  =  47)
Mean  SD  Mean  SD  pa
Duration  of  birth  (min) 14.16 4.8 14.51  4.7  0.7252
Duration of  surgery  (min)  56.06  11.75  57.21  10.88  0.6307
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dence  of  pruritus  2  h  after  intrathecal  injection  in  Group
S  compared  to  Group  A  (61.7%  vs.  30.23%,  respectively),  a
statistically  signiﬁcant  difference.  There  was  no  signiﬁcantStudent’s t-test.
Intraoperative  incidence  of  pruritus  and  drowsiness  was
igher  in  Group  S  (36.17%  and  23.4%)  than  in  Group  A  (4.55%
nd  0%,  respectively).
There  was  a  greater  tendency  of  bradycardia  in  Group  S
59.57%)  than  in  Group  A  (43.18%),  but  this  difference  was
ot  statistically  signiﬁcant.
There  was  no  signiﬁcant  difference  between  groups  in  the
ncidence  of  hypotension,  nausea,  vomiting,  decreased  oxy-
en  saturation  by  hemoglobin  (SpO2),  abdominal  discomfort,
nd  intraoperative  pain  (Table  6).
Table  4  Intraoperative  need  of  ephedrine.a
Group  A  (n  =  44)  Group  S  (n  =  47)
n  %  n  %
Yes  30  68.18  36  76.6
No 14  31.82  11  23.4
a p = 0.8074; chi-square.
dThere  was  no  signiﬁcant  difference  between  Apgar  scores
t  one  and  5  min,  95.45%  of  newborns  in  Group  A  and  95.75%
f  newborns  in  Group  S  had  scores  between  7  and  10  at  1  min
nd  all  infants  had  score  between  7 and  10  at  5  min  (Table  7).
Postoperative  evaluation  (Table  8)  showed  a higher  inci-ifference  in  the  incidence  of  pruritus  during  revaluation
Table  5  Latency  time  of  sensory  block  to  reach  T6.a
Group  A
(n  =  44)
Group  S
(n  =  47)
n  %  n  %
Up  to  5  min  31  70.45  40  85.11
6--10 min  9  20.45  3  6.38
11--15 min  1  2.27  3  6.38
>15 min  or  not  reached  3  6.82  1  2.13
a p = 0.1093, chi-square.
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Table  6  Intraoperative  complications.
Group  A  (n  =  44)  Group  S  (n  =  47)
n  %  n  %  p
Hypotension  36  81.82  37  78.72  0.7111a
Bradycardia  19  43.18  28  59.57  0.1178a
Nausea  17  38.64  16  34.04  0.6487a
Vomiting 9  20.45 6  12.77  0.3232a
Pruritus 2  4.55 17  36.17 c0.0001b
SpO2 <  95% 3  6.82 1  2.13 0.3504b
Drowsiness  0  0  11  23.4 c0.0005b
Abdominal  discomfort  5  11.36  1  2.13  0.1032b
Pain  1  2.27  1  2.13  1.0b
a Chi-square.
b Fisher’s exact.
c p < 0.05.
Table  7  Apgar  scores.
Valor  Apgar,  1  mina Apgar,  5  minb
Group  A  (n  =  44)  Group  S  (n  =  47)  Group  A  (n  =  44)  Group  S  (n  =  47)
n  %  n  %  n  %  n  %
<7  2  4.55  2  4.26  --  --  --  --
7--10 48  95.45  45  95.74  44  100  47  100
a
wp = 0.6663; Fisher’s exact.
b p = 1; Chi-square
times  at  six  and  12  h,  as  well  as  the  incidence  of  nausea  and
vomiting  in  all  times  (2,  6,  and  12  h).  Of  the  ﬁve  patients
who  experienced  episodes  of  vomiting  in  the  reevaluation
after  2  h,  only  one  persisted  with  vomiting  in  the  2nd  reval-
uation  (6  h).  The  other  four  occurrences  in  the  revaluation
at  6  h  corresponded  to  new  cases.
t
r
o
s
Table  8  Postoperative  side  effects.
Group  A  (n  =  44)  
n  %  
Pruritus
After  2  hc 13  30.23  
After  6  h  13  30.23  
After  12  h  6  13.95  
Nausea
After  2  h  5  11.63  
After  6  h  3  6.98  
After  12  h  4  9.3  
Vomiting
After  2  h  1  2.33  
After  6  h  1  2.33  
After  12  h  0  0  
a Chi-square.
b Fisher’s exact.
c p < 0.05.Regarding  the  occurrence  of  pain  at  rest  (VAS  >  3),  there
as  a  higher  incidence  in  Group  A  compared  to  Group  S in
he  revaluation  at  6  h  after  the  procedure  (18.18%  vs.  6.38%,
espectively),  but  statistically  not  signiﬁcant.  The  incidence
f  pain  (VAS  >  3)  12  h  after  spinal  anesthesia  tended  to  be
imilar  between  groups  (Table  9).
Group  S  (n  =  47)  p
n  %
29  61.7  0.0027a,c
18  38.3  0.4212a
8  17.02  0.6883a
5  12.77  0.8692a
4  8.51  0.5502b
1  2.13  0.1538b
4  8.51  0.2094b
4  8.51  0.2094b
0  0  --
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Table  9  Postoperative  pain  at  rest  (VAS  >  3).
Group  A  (n  =  44)  Group  S  (n  =  47)  p
n  %  n  %
After  2  h  3  6.82  4  8.51  0.5372b
After  6  h 8  18.18  3  6.38  0.0795b
After  12  h 13  29.55 13  27.66 0.0396a,c
a Chi-square.
b Fisher’s exact.
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iscussion
o  obtain  adequate  anesthesia  for  C-section,  an  intense
lockade  covering  from  the  sacral  (S2--S4)  to  the  visceral
bers  (T4--T12)  is  needed.  A  blockade  with  such  extension
esults  in  hypotension  by  blocking  the  sympathetic  ﬁbers.10
he  local  anesthetic  commonly  used  is  0.5%  hyperbaric  bupi-
acaine  at  doses  ranging  from  7.5  to  15  mg.  The  use  of  10  mg
lone  or  8  mg  combined  with  opioids  is  reported  as  ‘‘low
ose’’  by  some  authors,10 while  others  consider  ‘‘low  dose’’
nly  when  the  bupivacaine  mass  does  not  exceed  8  mg.3
Although  the  literature  show  a  trend  toward  bupivacaine
ose  reduction  up  to  doses  as  low  as  8  mg,  either  with  or
ithout  the  addition  of  lipophilic  opioids,  reducing  this  dose
o  levels  below  10  mg  without  epidural  catheter  insertion
ay  be  unsafe  due  to  the  potential  risk  of  failure  in  obtain-
ng  an  adequate  level  of  blockade  or  inadequate  blockade
uration  for  surgical  time,  which  increases  the  need  for
ntravenous  analgesic  agents  (fentanyl)  or  conversion  to  gen-
ral  anesthesia.3,8,9
Higher  incidence  of  intraoperative  hypertension  has  been
as  reported  in  patients  receiving  intrathecal  sufentanil
t  a  dose  of  5  g.17 Other  studies  of  sufentanil  at  doses
anging  from  2.5  to  10  g  failed  to  establish  a  signiﬁcant
elationship  between  the  use  of  intrathecal  sufentanil  and
ypotension,3,4,15,19 a  result  similar  to  that  observed  in  our
tudy.  However,  it  is  possible  that  the  addition  of  sufen-
anil  is  responsible  for  the  non-occurrence  of  the  expected
ecrease  in  the  incidence  of  hypotension  with  the  hyper-
aric  bupivacaine  dose  reduced  from  12.5  to  10  mg.
Although  there  was  a  higher  incidence  of  bradycardia  in
atients  who  received  sufentanil,  this  difference  was  not
tatistically  signiﬁcant.  This  relationship  was  not  observed
reviously  in  a  study  that  evaluated  the  incidence  of  brady-
ardia  in  patients  receiving  sufentanil  (10  g)  or  morphine
200  g)  by  the  same  route  of  administration.15
Several  studies  have  shown  that  intrathecal  sufentanil  is
elated  to  sedation15,17,19 and  that  sufentanil  is  more  sedat-
ng  than  spinal  morphine  (30%  vs.  5%,  respectively).15 These
esults  coincide  with  those  observed  by  us,  as  drowsiness
ccurred  in  23.4%  of  patients  receiving  sufentanil  and  was
bsent  in  the  group  that  received  only  morphine  as  an  adju-
ant.
A  study  comparing  different  doses  of  bupivacaine  alone
or  C-section  under  spinal  anesthesia  reported  35%  incidence
f  intraoperative  pain  with  a  dose  of  8  mg,  20%  with  a  dose
f  10  mg,  and  absent  with  a  dose  of  12  mg.9 We  found  no
ifferences  in  the  occurrence  of  this  effect  when  comparingyperbaric  bupivacaine  (12.5  mg)  combined  with  only  mor-
hine  with  hyperbaric  bupivacaine  (10  mg)  combined  with
orphine  and  sufentanil.  It  is  probable  that  the  addition
f  sufentanil  is  responsible  for  maintaining  the  quality  of
nalgesia  with  a  dose  reduction,  which  is  in  line  with  the
esults  observed  in  other  studies  shown  that  the  addition  of
ipophilic  opioid  drastically  reduces  the  occurrence  of  intra-
perative  pain  when  bupivacaine  is  used  at  doses  between
 and  10  mg.3,9,20
When  the  incidence  of  pruritus  was  compared  between
atients  who  received  intrathecal  bupivacaine  alone  and
atients  who  received  sufentanil  (10  g)  or  morphine
200  g)  combined  with  bupivacaine,  it  was  observed  that
he  incidence  was  signiﬁcantly  higher  in  patients  receiving
ufentanil  compared  to  those  receiving  morphine  (30%  vs.
0%,  respectively).15 It  was  also  shown  that  pruritus  resulting
rom  the  use  of  intrathecal  sufentanil  is  dose-dependent,
anging  from  34.3%  with  a  dose  of  2.5  g  to  68.6%  with  a  dose
f  5  g.17 Pruritus  induced  by  intrathecal  morphine  is  also
ose-dependent,  especially  in  doses  above  0.1  mg.21 In  our
tudy,  a  signiﬁcantly  higher  difference  in  pruritus  was  seen
n  patients  receiving  sufentanil,  in  the  intraoperative  period
nd  at  the  ﬁrst  assessment  2  h  after  anesthesia,  sufentanil
ction  period.
Thus,  in  the  present  study,  the  dose  reduction  of  0.5%
yperbaric  bupivacaine  from  12.5  10  mg,  combined  with
ufentanil  (5  g)  at  the  lowest  dose,  maintained  the  same
uality  of  anesthesia,  but  did  not  reduce  the  incidence  of
ypotension  and  increased  the  incidence  of  pruritus  and
edation.
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